HRAS is detected as a mutational cancer driver in Bladder Urothelial Carcinoma
HRAS reports in Bladder Urothelial Carcinoma (BLCA)
Cancer type details
Bladder Urothelial Carcinoma |
---|
Cohorts
8
Samples 905 Mutations 6,585,575 Driver genes 89 |
Gene details
HRAS |
---|
Ensembl ID
ENSG00000174775
Transcript ID ENST00000451590 Protein ID ENSP00000407586 |
Cohorts where is driver
4
Mutated samples 48 Mutated samples (%) 5.30 Mutations 53 |
Mode of action Activating |
Known driver True |
Method signals per Cohort
Cohort | Methods | Samples | Samples (%) |
---|
In-silico saturation mutagenesis
Model | Mutations | Driver mutations | Driver mutations (%) |
---|---|---|---|
BLCA (Bladder Urothelial Carcinoma) | 1692 | 47 | 2.78 |
Observed mutations in tumors
Mutation (GRCh38) | Protein Position | Samples | Samples (%) | Consequence | Driver | Driver score |
---|